Renaissance Partners, an investment firm headquartered in Italy, is set to acquire Genetic S.p.A. The acquisition will be made in collaboration with Aurora Growth Capital and the Pavese family. Genetic S.p.A. is a prominent Italian pharmaceutical company specializing in contract development and manufacturing within the respiratory and ophthalmic therapeutic sectors.
Paul, Weiss is providing legal advice to Renaissance Partners on the English law financing aspects of this transaction. The team from Paul, Weiss includes corporate partners Matthew Merkle, Neel Sachdev, and Nicolò Ascione.
